XML 25 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Expenses    
Research and development $ 8,082,510 $ 11,606,197
General and administrative 4,189,068 4,705,674
Total expenses 12,271,578 16,311,871
Loss from operations (12,271,578) (16,311,871)
Foreign exchange losses (9,392) (6,313)
Investment income 129,805 490,984
Net loss $ (12,151,165) $ (15,827,200)
Net loss per share, basic and diluted $ (0.31) $ (0.41)
Weighted average shares outstanding, basic and diluted 39,177,592 38,968,110